Olmesartan
Olmesartan Basic information
- Product Name:
- Olmesartan
- Synonyms:
-
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
- Olmesartan
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-(1H-tetazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid
- CS 088
- Olmesartan Acid
- Olmesartan Medoxomil-1
- CS-415
- Olmesartan (Olmesartan Medoxomil EP Impurity A)
- CAS:
- 144689-24-7
- MF:
- C24H26N6O3
- MW:
- 446.5
- EINECS:
- 646-413-5
- Product Categories:
-
- Bases & Related Reagents
- Intermediates & Fine Chemicals
- Nucleotides
- Pharmaceuticals
- Isotope Labeled Compounds
- Mol File:
- 144689-24-7.mol
Olmesartan Chemical Properties
- Melting point:
- 186-188°C
- Boiling point:
- 738.3±70.0 °C(Predicted)
- Density
- 1.33
- storage temp.
- 2-8°C
- solubility
- DMSO (Slightly), Methanol (Slightly, Heated)
- pka
- 2.39±0.50(Predicted)
- form
- powder
- color
- white to beige
- Stability:
- Hygroscopic
- CAS DataBase Reference
- 144689-24-7(CAS DataBase Reference)
Safety Information
- RTECS
- NI4014100
- HS Code
- 29339900
- Hazardous Substances Data
- 144689-24-7(Hazardous Substances Data)
Olmesartan Usage And Synthesis
Chemical Properties
White Solid
Uses
An labelled angiotensin II receptor antagonist. Used as an anti-hypertensive
Uses
Angiotensin II inhibitor, antihypertensive
Uses
An angiotensin II (AT1) receptor antagonist
Uses
Olmesartan Acid (Olmesartan EP Impurity A) is an angiotensin II receptor antagonist. Used as an anti-hypertensive.
Definition
ChEBI: Olmesartan is a biphenylyltetrazole. It has a role as an antihypertensive agent and an angiotensin receptor antagonist.
General Description
Olmesartan medoxomil, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (Benicar, Olmetec) uses the tetrazolering system as its acidic system, which participates inreceptor binding.When administered to a patient, the drugis rapidly and completely bioactivated by ester hydrolysis ofthe medoxomil during absorption from the gastrointestinaltract. Once the prodrug is converted to the active form, virtuallyno further metabolism occurs. In September 2007, theFood and Drug Administration (FDA) approved its use as acombination product with the calcium channel blocker amlodipinefor the management of hypertension. This combinationproduct is sold under the tradename of Azor.
Biochem/physiol Actions
Olmesartan possesses anti-inflammatory and anti-oxidative stress properties. It protects neuronal cells against oligomerized amyloid β (Aβ)-induced cellular senescence.
storage
Store at +4°C
OlmesartanSupplier
- Tel
- 0531-88987162 18615427082
- 2823799053@qq.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 400-021-7337 2355568890
- sales@demochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
Olmesartan(144689-24-7)Related Product Information
- Propyl butyrate
- Isopropyl alcohol
- Hydroxyethyl Cellulose
- N,N-Diisopropylethylamine
- Dextromethorphan
- Ethyl maltol
- Propyl gallate
- Dextromethorphan hydrobromide monohydrate
- Olmesartan Medoxomil
- Biphenyl
- CHLOROPHOSPHONAZO III
- Levamisole
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester
- Olmesartan
- 4-CHLOROMETHYL-5-METHYL-1,3-DIOXOL-2-ONE (INTERMEDIATE OF OLMESARTAN MEDOXOMIL)
- Olmesartan intermediate
- 4-(1-Methoxy-1-methylethyl)-2-propyl-1H-Imidazole-5-carboxylic acid ethyl ester
- Diethyl 2-propylImidazoledicarbonate